Expert Opinion on Optimal Testosterone Control in Prostate Cancer

In order to reflect previous agreements with a larger group of experts in the field, questions regarding “Optimal testosterone control in Prostate Cancer” were asked to the delegates of the Discussion Forum using an interactive voting system. Before the interactive voting session, the currently published data were presented to the audience. Similar to the experts, the delegates also indicated that achieving “the lowest testosterone level possible” is their main goal of hormone therapy. 64% of the delegates agreed that they would consider a castrate level of below or equal to 20 ng/dL to be optimal.